The kidney transplant market has been witnessing significant growth over the past few years owing to the rising prevalence of chronic kidney diseases and end-stage renal disease across the globe. As per recent studies, around 2 million people suffer from end-stage renal disease worldwide, requiring either dialysis or kidney transplant for survival. Furthermore, lifestyle changes such as obesity, poor diet, and lack of exercise have increased the risk of developing kidney problems over time.

Market Dynamics:

The global kidney transplant market is driven by the increasing elderly population, rising healthcare expenditure, growing awareness about organ donation, and technological advancements in transplant procedures. However, high cost associated with transplant surgeries, lack of organ donors in various countries, and risk of organ rejection are some of the factors expected to restrain the market growth. On the other hand, improving healthcare infrastructure in developing nations, favorable government policies for organ donation, and emerging biosimilars provide lucrative opportunities in the near future.

Key Features of the Study:

• This report provides an in-depth analysis of the global kidney transplant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global kidney transplant market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Fresenius Medical Care AG & Co. KGaA, Getinge AB, B. Braun Melsungen AG, Terumo Corporation, and Baxter International Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global kidney transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global kidney transplant market

Detailed Segmentation-

• By Type
  
  • Living Donor Transplant
  • Paired Kidney Transplant
  • Deceased Donor Transplant
    
• By Age Group
  
  • Children
  • Adults
    
• By End Users
  
  • Hospitals & Clinics
  • Transplant Centres
  • Academic and Research Institutes
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Sanofi
  • Sangamo Therapeutics, Inc.
  • Pfizer, Inc.
  • Novartis AG
  • Braun Melsungen AG
  • Fresenius Medical Care
  • Medtronic
  • Preservation Solution Inc.
  • TransMedics, Inc.
  • Organ Recovery Systems
  • Transonic Systems Inc.
  • CareDx
  • DaVita Kidney Care
  • ZONAL TRANSPLANT CO-ORDINATION CENTRE
  • Histogen
  • Hoffmann-La Roche Ltd.
  • Astellas Pharma, Inc.
  • Bristol-Myers Squibb Company
  • OrganOx Limited
  • Terumo Corporation